Oncovista Innovative Therapies Stock Net Income
| OVITDelisted Stock | USD 0.0001 0.00 0.00% |
Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of OncoVista Innovative, as well as the relationship between them.
Analyzing historical trends in various income statement and balance sheet accounts from OncoVista Innovative's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting OncoVista Innovative's valuation are summarized below:OncoVista Innovative Therapies does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. OncoVista |
Search Suggestions
| OV | One Valley Bancorp | CompanyDelisted |
| OVV | Ovintiv | Company |
| OVB | Overlay Shares Core | ETF |
| OVX | CBOE Crude Oil | Index |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, OncoVista Innovative Therapies reported net income of (2.54 Million). This is 100.75% lower than that of the Biotechnology sector and 103.63% lower than that of the Health Care industry. The net income for all United States stocks is 100.45% higher than that of the company.
OncoVista Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OncoVista Innovative's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of OncoVista Innovative could also be used in its relative valuation, which is a method of valuing OncoVista Innovative by comparing valuation metrics of similar companies.OncoVista Innovative is currently under evaluation in net income category among its peers.
OncoVista Fundamentals
| Return On Asset | -23.58 | |||
| Current Valuation | 852.92 K | |||
| Shares Outstanding | 23.56 M | |||
| Price To Earning | (0.12) X | |||
| Price To Book | 26.09 X | |||
| EBITDA | (3.4 M) | |||
| Net Income | (2.54 M) | |||
| Cash And Equivalents | 61.27 K | |||
| Total Debt | 479.3 K | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (0.28) X | |||
| Cash Flow From Operations | (232.38 K) | |||
| Earnings Per Share | (0.15) X | |||
| Beta | -51.97 | |||
| Market Capitalization | 558.34 K | |||
| Total Asset | 12.51 K | |||
| Retained Earnings | (27.6 M) | |||
| Working Capital | (5.89 M) | |||
| Current Asset | 61 K | |||
| Current Liabilities | 5.95 M | |||
| Net Asset | 12.51 K |
About OncoVista Innovative Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OncoVista Innovative Therapies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OncoVista Innovative using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OncoVista Innovative Therapies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in OncoVista Pink Sheet
If you are still planning to invest in OncoVista Innovative check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoVista Innovative's history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |